CoverageForm 410-K10-Q8-K13D13G13F

Versant Venture Capital VI, L.P.

CIK 0001687880
10% Owner

Filings

22

Latest Oct 2, 2025

Issuers covered

9

Showing

22 of 22

Page 1

Track record

44 of 57 open-market trades scored (77% price coverage) - 13 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

HorizonTradesWin rateAvgMedianBestWorst
30 days4443%+4.3%-3.1%+34.6%-44.2%
90 days4475%+22.3%+30.4%+64.5%-51.8%
180 days4493%+56.2%+68.1%+82.2%-9.2%
365 days1050%+7.0%+9.3%+57.7%-33.4%

Issuers

Companies where Versant Venture Capital VI, L.P. has filed

TickerIssuerFilingsLast filed
GRPHGraphite Bio, Inc.9Oct 2, 2025
GLUEMonte Rosa Therapeutics, Inc.3Oct 30, 2024
LVTXLava Therapeutics NV2Sep 23, 2025
OYSTOyster Point Pharma, Inc.2Jan 4, 2023
TPSTTempest Therapeutics, Inc.2Aug 12, 2024
BDTXBlack Diamond Therapeutics, Inc.1Aug 30, 2024
IPSCCentury Therapeutics, Inc.1Feb 2, 2022
CTNMContineum Therapeutics, Inc.1Apr 11, 2024
RPTXRepare Therapeutics Inc.1Jun 7, 2022

All filings

22 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue